Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of BAIBA in Healthy Individuals
NCT04785170Completed
- Sponsor
- Vedic Lifesciences
- Start
- Feb 2021
- Primary completion
- Mar 2021
- Countries
- 1
01
Overview
Open-label, single-arm trial in obesity, sponsored by Vedic Lifesciences. Primary endpoint: Adverse Events at 14 Days. Started Feb 2021; status: completed.
02
Conditions
obesity
Beyond the preview
Go deeper on NCT04785170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04785170.